Skip to main content
OpenTrials
Completed

NCT Number: NCT03038659

Role of Intima-media Thickness in Determining Arteriogenic Erectile Dysfunction

Erectile dysfunction.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The intima media thickness is increasingly used as a surrogate end point of vascular outcomes in clinical trials aimed at determining the success of interventions that lower risk factors for atherosclerosis and associated diseases (stroke, myocardial infarction and peripheral artery diseases, like disease of cavernosal artery). The investigators hypothesized that the IMT of cavernosal artery would add to the predictive value of vasculogenic erectile dysfunction risk and outcomes. This study seeks to evaluate these hypotheses with our experience, investigating the predictive accuracy of Cavernosal Doppler ultrasound findings for discriminating patients with vasculogenic erectile dysfunction.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Erectile dysfunction patients

Exclusion criteria

  • Penile trauma.

Treatment and study plan

Penile Duplex

Device

Measuring intima media thickness

Primary outcomes

  1. erectile dysfunction

    Time frame: six months

    intima media thickness

Sponsors and collaborators

Lead sponsor

Adam International Hospital

Other

Registry information

Official study title

Predictive Value of Measuring Intima-media Thickness of Cavernosal Artery in Diagnosis of Arteriogenic Erectile Dysfunction by Penile Duplex

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Feb 1, 2017
Registry last updated
Feb 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.